Blog

Always up to date

Insights, recommendations and current trends in the field of intellectual property law

14.08.2025

Mention in IAM Strategy 300

Two of our partners, Dr. Dirk Schulz and Guido Quiram, have been included in the latest edition of the prestigious IAM Strategy 300 - an international award given only to the world's leading figures in the field of IP strategy. The list recognizes ...

Read article

06.08.2025

New referral to the Enlarged Board of Appeal of the EPO: G 1/25 (“Hydroponics”) - Adaptation of the description before grant

The EPO has a long-standing practice of adapting the description in order to align it with the allowable claims prior to grant. This practice became a matter of debate after the EPO had revised its examination guidelines to take a stricter approach.

Read article

14.07.2025

G 1/23: Novelty / Availability to the Public / Reproducibility

The Enlarged Board of Appeal clarifies the conditions for a product and its composition to belong to the state of the art

Read article

22.06.2025

The CRISPR-Cas9 Patent Battle: All Back to Zero? Think Again!

Who really owns CRISPR-Cas9? More than a decade after the first patent filings, the legal battle over this revolutionary gene-editing technology is still raging—with surprising twists, major revocations, and unexpected comebacks. In our latest article, based on a webinar by Dr. Ulrich Storz, we unravel the complex patent landscape and explain why “all back to zero” may not be the end, but just the next chapter. A must-read for anyone in biotech, IP, or innovation strategy.

Read article